Pharmacogenetic differences in response to albuterol between Puerto Ricans and Mexicans with asthma.
about
Latino populations: a unique opportunity for the study of race, genetics, and social environment in epidemiological researchDissecting complex diseases in complex populations: asthma in latino americansPharmacogenetics of healthy volunteers in Puerto RicoIntegrative systems biology approaches in asthma pharmacogenomicsAsthma in Hispanics. An 8-year updateAssociation of β₂-adrenergic receptor polymorphism with work-related symptoms in workers exposed to wheat flourAn American Thoracic Society/National Heart, Lung, and Blood Institute workshop report: addressing respiratory health equality in the United StatesThe role of pharmacogenomics in improving the management of asthmaWarfarin Anticoagulation Therapy in Caribbean Hispanics of Puerto Rico: A Candidate Gene Association Study.Recent human evolution has shaped geographical differences in susceptibility to diseaseGSNO reductase and beta2-adrenergic receptor gene-gene interaction: bronchodilator responsiveness to albuterol.Dual-specificity phosphatase 1 as a pharmacogenetic modifier of inhaled steroid response among asthmatic patientsALOX5AP and LTA4H polymorphisms modify augmentation of bronchodilator responsiveness by leukotriene modifiers in Latinos.Factors predicting inhaled corticosteroid responsiveness in African American patients with asthma.Genetic variations in GRIA1 on chromosome 5q33 related to asparaginase hypersensitivity.Ethnic-specific differences in bronchodilator responsiveness among African Americans, Puerto Ricans, and Mexicans with asthma.ORMDL3 gene is associated with asthma in three ethnically diverse populationsPharmacogenomics of the response to IFN-beta in multiple sclerosis: ramifications from the first genome-wide screen.Very important pharmacogene summary ADRB2.Genotype-environment interactions and their translational implications.Asthma pharmacogenetics and the development of genetic profiles for personalized medicineCosmopolitan and ethnic-specific replication of genetic risk factors for asthma in 2 Latino populationsApolipoprotein ε4 is associated with lower brain volume in cognitively normal Chinese but not white older adultsGenome-wide association study of short-acting β2-agonists. A novel genome-wide significant locus on chromosome 2 near ASB3.Asthma mortality in Puerto Rico: 1980-2007.Association of corticotropin-releasing hormone receptor-2 genetic variants with acute bronchodilator response in asthma.Modest genetic influence on bronchodilator response: a study in healthy twins.The pharmacogenetics and pharmacogenomics of asthma therapyEthnicity-specific gene-gene interaction between IL-13 and IL-4Ralpha among African Americans with asthma.Applying epidemiologic concepts of primary, secondary, and tertiary prevention to the elimination of racial disparities in asthma.Stress and Bronchodilator Response in Children with Asthma.How pharmacogenomics will play a role in the management of asthma.A case-control study of innate immunity pathway gene polymorphisms in Puerto Ricans reveals association of toll-like receptor 2 +596 variant with asthmaAsthma in Hispanics.Genetic determinants and ethnic disparities in sepsis-associated acute lung injury.Admixture-matched case-control study: a practical approach for genetic association studies in admixed populations.Update in asthma 2005.Development of a pharmacogenetic-guided warfarin dosing algorithm for Puerto Rican patientsPharmacogenomics of beta2-agonist: key focus on signaling pathways.Recent development in pharmacogenomics: from candidate genes to genome-wide association studies.
P2860
Q24544919-811A4FDB-EB2C-4B39-86C7-758C92CAF787Q24648496-B4716E71-56E2-4DF7-BAD2-FE96E1AA3239Q26779038-5888C26D-F2F1-4C7A-99A2-551AEBF7E3CDQ26861541-25C9A120-9366-40CD-88E2-9DD8949028E3Q27024693-142BA3BD-9EDF-47CE-88F8-27F78FC033D1Q28388736-004161BC-AE6D-4147-A55F-E8499C2E4A4EQ32984871-98B414FB-D5A8-4A11-928B-484641263E6EQ33669054-FA32E64D-7CCC-4FCE-B616-86CB1681992DQ33770184-467C2FEB-B7D0-4102-B135-4F7ECAD5DACDQ33801623-04D1D07B-F7CA-4666-B75D-9F00E82D8513Q33905430-2053F524-D2A9-4215-BD22-D2F7B8477301Q34143925-19ADDFC8-D289-4FED-8032-5554C106E2C6Q34176597-6CD7A0B7-63D2-4CB3-90DC-42E26694F130Q34388432-B0A3AA8E-65A8-401E-9149-479774FAD2BEQ34400003-1AB0B419-6454-47A6-9F43-C92418431916Q34702650-D0947479-F848-42BC-817C-D83295A184ADQ34756865-DA4F693B-00D0-4FF1-A359-D035101DC5F0Q34777373-C8417DF2-E4CB-495C-8581-A7C17217999EQ34994884-61225FDD-7B9F-4EC2-BFA0-B43858899D95Q35024668-9CE64305-A2B2-44A8-976B-74E11484B5A4Q35076452-C721740A-7D84-4962-BA98-97C611620AE3Q35085622-7FC40163-9C0C-4AC6-8EEF-D5174EE1CB3AQ35147749-E71F7969-7BDB-477E-BD3F-F7CFE2B96BABQ35261929-1966381C-567C-4CCD-A2F3-42AA40A29FD8Q35313274-5B136B64-4C83-4CAC-8252-0BFB493B0DAFQ35525863-6A5BB252-23B4-440F-9098-00FA8161CCBFQ35539568-19788E1B-D6EA-4221-9FF1-917163B57C10Q35819993-F9DA1781-9208-4FC1-BD51-14E6C3F41EB7Q35855230-DEF5B96B-1E2C-406F-B854-94BF5473FED3Q35865723-0EE9D6F3-0D92-4094-8778-31AC589575B2Q35879689-3AD6DC31-C04D-41C2-9CC5-1D2764939729Q36075209-9B1001BC-5148-4657-932C-1D37119364F3Q36096390-90FDE8A3-B490-4A9C-945A-E9B892819D53Q36279538-096BEA0A-89F6-443C-8FA2-BABD122B6533Q36284853-E4368D2B-BF67-4EDE-8C29-039D70C93B52Q36338286-4CBC64BE-F239-4234-A7BD-CB6B7C39DE85Q36429918-8B458A4D-45FD-4D78-B4C3-82ED0A4F6C63Q36511894-2FCD52D8-ADBB-49C0-B98F-DBDD8EFF8E32Q36596722-979DD621-1D6F-4DE5-8A64-AF8F1CAA401BQ36874335-6BCC64DF-7123-4D2A-B39C-DEACED49263F
P2860
Pharmacogenetic differences in response to albuterol between Puerto Ricans and Mexicans with asthma.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Pharmacogenetic differences in ...... cans and Mexicans with asthma.
@en
Pharmacogenetic differences in ...... cans and Mexicans with asthma.
@nl
type
label
Pharmacogenetic differences in ...... cans and Mexicans with asthma.
@en
Pharmacogenetic differences in ...... cans and Mexicans with asthma.
@nl
prefLabel
Pharmacogenetic differences in ...... cans and Mexicans with asthma.
@en
Pharmacogenetic differences in ...... cans and Mexicans with asthma.
@nl
P2093
P2860
P1476
Pharmacogenetic differences in ...... cans and Mexicans with asthma.
@en
P2093
Alfonso Torres
Craig Lilly
Dean Sheppard
Edwin K Silverman
Esteban González Burchard
Henry Matallana
Homer A Boushey
Ivan Gomez
Jean G Ford
P2860
P304
P356
10.1164/RCCM.200409-1286OC
P407
P577
2004-11-19T00:00:00Z